Diabetes Technology

Feature Archive

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

Latest

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.

Dual-Hormone Artificial Pancreas Reduces Glucose Variability in T1D

Dual-Hormone Artificial Pancreas Reduces Glucose Variability in T1D

Investigators conducted a randomized crossover comparison of 2 dual-hormone artificial pancreas systems — one with rapid insulin and amylin, and another with regular insulin and amylin — with a rapid insulin-alone artificial pancreas.

Improved Glycemic Control With Closed-Loop Insulin Delivery System

Improved Glycemic Control With Closed-Loop Insulin Delivery System

Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.

MiniMed 670G System Approved for Use in Younger Patients With T1D

MiniMed 670G System Approved for Use in Younger Patients With T1D

The MiniMed 670G system measures glucose levels every 5 minutes and automatically adjusts insulin delivery to avoid highs and lows.

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

Participants completed surveys for fear of hypoglycemia, hypoglycemia unawareness, and problem areas in diabetes questionnaire.

Sign Up for Free e-Newsletters



CME Focus